John O'Bryan to Antibodies, Monoclonal
This is a "connection" page, showing publications John O'Bryan has written about Antibodies, Monoclonal.
Connection Strength
0.749
-
Inhibition of RAS function through targeting an allosteric regulatory site. Nat Chem Biol. 2017 Jan; 13(1):62-68.
Score: 0.454
-
Selective and noncovalent targeting of RAS mutants for inhibition and degradation. Nat Commun. 2021 05 11; 12(1):2656.
Score: 0.155
-
Therapeutic targeting of RAS: New hope for drugging the "undruggable". Biochim Biophys Acta Mol Cell Res. 2020 02; 1867(2):118570.
Score: 0.140